ImmunoPrecise (IPA) Total Business Assets

Corporate emblem and logo of immunoprecise.com (IPA)

ImmunoPrecise Antibodies (IPA) is facing a liquidity shortage and a gradual depletion of resources due to R&D costs amid weak revenue. Business growth is being driven by AI services and licensing agreements for antibody discovery. This price chart on GURU.Markets, where total asset value stands at 37.92, confirms its status as a molecular biology leader implementing the LENSai platform for precise target analysis.

ImmunoPrecise Antibodies (IPA) Company Total Assets: for the period 07/04/2022 - 09/04/2025

Comprehensive metric breakdowns and analytics for immunoprecise.com (IPA)

- price and consensus price forecast:
Share Price ImmunoPrecise Antibodies Ltd.|IPA - Price Target Chart
- market capitalization data:
Market Capitalization ImmunoPrecise Antibodies Ltd.|IPA - Enterprise Value
- book capitalization data:
Book Value per Share ImmunoPrecise Antibodies|IPA - Book Capitalization|Market Capitalization to Book Value immunoprecise.com|IPA - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio ImmunoPrecise Antibodies|IPA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio ImmunoPrecise Antibodies Ltd.|IPA - Company Total Debt|Debts to Book Capitalization ImmunoPrecise Antibodies Ltd.|IPA - Company Long-Term Debt|Company Short-Term Indebtedness ImmunoPrecise Antibodies
Fundamental valuation:ImmunoPrecise, IPA
Finished products of ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies (IPA) balances operational risks and capital efficiency by integrating generative AI and the BioStrand antibody discovery platform, while an analysis of controlled resource changes on GURU.Markets, reverse-engineered via ROA, enables a real-time assessment of asset value and inflation resilience, distinguishing market leadership from dangerous overheating.

Analysis of competing companies

TEM (Tempus AI, Inc) - Total Business Assets|Aggregate Company Assets Qiagen (QGEN)|Total Business Assets Ionis Pharmaceuticals, Inc.|Company Total Assets RGEN|Company Total Assets Avidity Corp (RNA)|Company Total Assets CRSP|genedx.com - Company Total Asset Base|RARE: Aggregate Company Assets|BEAM: Cumulative Company Assets|SRPT (Sarepta Therapeutics Inc) - Aggregate Company Assets|Cumulative Company Assets Twist Bioscience Corp|TXG (10x Genomics, Inc.) - Cumulative Company Assets|Company Total Assets NTLA|Aggregate Company Assets Stoke Therapeutics, Inc. STOK|Total Business Assets BLFS (BioLife Solutions Inc)|WVE: Aggregate Company Assets|Maze Therapeutics Corp - Company Assets|Aggregate Company Assets Sionna Therapeutics Inc|PRME: Total Asset Value of Company|Aggregate Company Assets Taysha Gene Therapies, Inc. TSHA|uniQure NV (QURE) - Aggregate Asset Value|Company Total Assets MGTX (MeiraGTx PLC)|Company Assets REGENXBIO Corp|Company Total Assets SLDB (Solid Biosciences Inc.)|Cumulative Company Assets ocugen.com (OCGN)|Company Total Assets PACB|Benitec Biopharma Inc - Company Total Asset Base|Aggregate Company Assets DSGN (Design Pharma)|RCKT - Company Total Asset Base|Company Total Assets FDMT|Company Assets Lexeo Therapeutics, Inc.|KRRO - Cumulative Company Assets|Aggregate Asset Value Editas Medicine Inc|Company Total Assets SLN|Company Total Assets PRQR (proqr.com)|CDXS - Aggregate Company Assets|SGMO - Total Business Assets|Cumulative Company Assets Nautilus Biotechnology Inc NAUT|MGX - Aggregate Business Assets|Precision BioSciences, Inc. - Company Total Assets|Generation Bio (GBIO) - Company Total Asset Base|Company Total Assets Boundless Bio, Inc.|Aggregate Company Assets XCUR|Imunon, Inc. - Aggregate Company Assets|Company Assets phiopharma.com (PHIO)|MBIO - Company Total Assets|Total Business Assets TransCode Therapeutics Inc. RNAZ|Company Total Assets BNGO (Bionano)|APDN - Company Total Asset Base|Company Total Assets BLUE|OMGA (Omega Therapeutics Inc) - Company Assets|OMIC: Aggregate Company Assets|Company Total Asset Base Regulus|SYRS (Syros Pharmaceuticals) - Company Total Assets|Company Total Asset Base TBIO (telesisbio.com)|TRACON Pharmaceuticals, Inc. (TCON) - Aggregate Company Assets|Total Asset Value of Company Unity Biotechnology Inc. UBX